Incidence of antibody–drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of antibody–drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis

Published:2024-04 Issue: Volume:196 Page:104292
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Zhang Hengheng,Shen GuoShuang,Yang Ping,Li Jinming,Li Zitao,Liu Zhen,Wang Miaozhou,Zhao Fuxing,Ren Dengfeng,Liu Zhilin,Zhao Jiuda,Zhao Yi

Publisher

Elsevier BV

Reference69 articles.

1. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors;Abrahams;Ann. Oncol.,2016

2. Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape;Adams;ESMO Open,2021

3. ADC Could Benefit Some with Breast Cancer, 2019. Cancer Discov. 9, 570–570. https://doi.org/10.1158/2159-8290.CD-NB2019-034.

4. The HPA axis and the genesis of chronic fatigue syndrome;Aj;Trends Endocrinol. Metab. TEM,2004

5. An ADC for Triple-Negative Breast Cancer, 2016. Cancer Discov. 6, OF8–OF8. https://doi.org/10.1158/2159-8290.CD-NB2015-162.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP